Jakub Hofman

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Cancer Stem Cells

Epidermal Growth Factor Receptor

Clinical Evaluation

Top Venues

Drug metabolism and disposition: the biological fate of chemicals

Molecular pharmaceutics

International journal of molecular sciences

Charles University, Faculty of Pharmacy

Charles University, Faculty of Pharmacy in Hradec Kralove (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Charles University, Faculty of Pharmacy Jul 1o 2015

Czechia

academic research and teaching fellow :: Department of Pharmacology and Toxicology

Education History

Charles University, Faculty of Pharmacy in Hradec Kralove Oct 1o 2008 - Oct 26o 2012

Czechia

PHD :: Department of Pharmacology and Toxicology

Publications

Ziba Sabet, Dimitrios Vagiannis, Youssif Budagaga, Yu Zhang, Eva Novotná, Ivo Hanke, Tomáš Rozkoš, Jakub Hofman
Talazoparib Does Not Interact with ABCB1 Transporter or Cytochrome P450s, but Modulates Multidrug Resistance Mediated by ABCC1 and ABCG2: An in Vitro and Ex Vivo Study. International journal of molecular sciences 23 (22) (2022)
Jakub Hofman, Ales Sorf, Dimitrios Vagiannis, Simona Sucha, Eva Novotna, Sarah Kammerer, Jan-Heiner Küpper, Martina Ceckova, Frantisek Staud
Interactions of Alectinib with Human ATP-Binding Cassette Drug Efflux Transporters and Cytochrome P450 Biotransformation Enzymes: Effect on Pharmacokinetic Multidrug Resistance. Drug metabolism and disposition: the biological fate of chemicals 47 (7) (2019)
Jakub Hofman, Ales Sorf, Dimitrios Vagiannis, Simona Sucha, Sarah Kammerer, Jan-Heiner Küpper, Si Chen, Lei Guo, Martina Ceckova, Frantisek Staud
Brivanib Exhibits Potential for Pharmacokinetic Drug-Drug Interactions and the Modulation of Multidrug Resistance through the Inhibition of Human ABCG2 Drug Efflux Transporter and CYP450 Biotransformation Enzymes. Molecular pharmaceutics 16 (11) (2019)